SNORA50C and lung carcinoma: However, snoRA76 displayed a significant decrease in expression in AA patients with lung cancer compared with that in controls (Mann–Whitney U test: P < 0.05; FDR-adjusted P < 0.05; Table 3; Fig. 1; Supplementary Fig. S1).